PHARMACEUTICAL
manufacturer Phebra this morning
issued a statement calling for the
establishment of a National
Antidote Inventory to help with the
emergency treatment of victims of
poisoning.
Phebra ceo Mal Eutick said a
central inventory would improve the
safety and security of supply of
antidotes in Australian hospitals.
“Our experience is that hospitals
around the country often don’t
always have the antidote they
urgently require, and sometimes
they do not have enough to treat
an affected patient,” he said.The above article was sent to subscribers in Pharmacy Daily's issue from 12 Jul 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 12 Jul 10
MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.
AUSTRALIA’S public hospitals are facing their lengthiest wait times on record for planned surgeries, with emergency departments struggling under access blockages, according to the latest annual Public Hospital Report Card by the Australian Medical Association (AMA).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.